References
- Castelli F, Puglia C, Sarpietro M-G, Rizza L, Bonina F. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Int J Pharm 2005; 304: 231–238
- Han F, Li S, Yin R, Liu H, Xu L. Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: nanostructured lipid carriers. Colloids Surf A: Physicochem Eng Asp 2008; 315: 210–216
- Hu F-Q, Zhang Y, Du Y-Z, Yuan H. Nimodipine loaded lipid nanospheres prepared by solvent diffusion method in a drug saturated aqueous system. Int J Pharm 2008; 348: 146–152
- Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S. Preparation and characteristics of monostearin nanostructured lipid carriers. Int J Pharm 2006; 314: 83–89
- Hu FQ, Yuan H, Zhang HH, Fang M. Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int J Pharm 2002; 239: 121–128
- Imai Y, Ujiie N, Nakamur A, Koshinuma M, Tajima K. Three-phase structure of hexadecane nanoemulsion formed with phospholipid–surfactant mixtures and its novel phase transition temperature TE. Colloids Surf A Physicochem Eng Asp 2006; 276: 134–142
- Jenning V, Thünemann AF, Gohla SH. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 2000; 199: 167–177
- Joshi M, Pathak S, Sharma S, Patravale V. Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject. Int J Pharm 2008; 346: 119–126
- Li X, Nie S-F, Kong J, Li N, Ju C-Y, Pan W-S. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int J Pharm 2008; 363: 177–182
- Lin X, Li X, Zheng L, Yu L, Zhang Q, Liu W. Preparation and characterization of monocaprate nanostructured lipid carriers. Colloids Surf A Physicochem Eng Asp 2007; 311: 106–111
- Müller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 2002; 242: 121–128
- Marcos GF, Maria JA, Dolores T. Design and characterization of a new drug nanocarrier made from solid–liquid lipid mixtures. J Colloid Interf Sci 2005; 285: 590–598
- Mehnert W, Mader K. Solid lipid nanoparticles production, characterization and applications. Adv Drug Del Rev 2001; 47: 165–196
- Muèller RH, Maèder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art. Eur J Pharm Biopharm 2000; 50: 161–177
- Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Del Rev 2002; 54: S131–S155
- Shahgaldian P, Silva ED, Coleman AW, Rather B, Zaworotko MJ. Para-acyl-calix-arene based solid lipid nanoparticles (SLNs): a detailed study of preparation and stability parameters. Int J Pharm 2003; 253: 23–38
- Souto EB, Wissing SA, Barbosa CM. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 2004; 278: 71–78
- Souto EB, Wissing SA, Barbosa CM, Müller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 2004; 278: 71–77
- Teeranachaideekul V, Souto EB, Junyaprasert VB, Muller RH. Cetyl palmitate-based NLC for topical delivery of coenzyme Q10—development, physicochemical characterization and in vitro release studies. Eur J Pharm Biopharm 2007; 67: 141–148
- Trotta M, Debernardi F, Caputo O. Preparation of solid lipid nanoparticles by a solvent emulsification–diffusion technique. Int J Pharm 2003; 257: 153–160
- Yuan H, Wang L-L, Du Y-Z, You J, Hu F-Q, Zeng S. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification colloids. Surf B Biointerfaces 2007; 60: 174–179